Assignee
PROTHENA BIOSCIENCES LTD
IE·57 granted patents·51 pending applications·324 citations·filing 2013–2025
Top patents by PatentIndex Score
108 records- 0197US10961302B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Mar 30, 2021·7 cites·38 claims
- 0297US9884906B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2016·Granted Feb 6, 2018·12 cites·20 claims
- 0396US10752679B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Aug 25, 2020·11 cites·30 claims
- 0496US10633433B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2016·Granted Apr 28, 2020·9 cites·43 claims
- 0596US10501531B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2014·Granted Dec 10, 2019·16 cites·26 claims
- 0696US10464999B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2016·Granted Nov 5, 2019·11 cites·78 claims
- 0796US10450369B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Oct 22, 2019·7 cites·43 claims
- 0896US9670273B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2015·Granted Jun 6, 2017·15 cites·21 claims
- 0995US10889638B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Jan 12, 2021·12 cites·196 claims
- 1095US10669330B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Jun 2, 2020·8 cites·32 claims
- 1195US10118960B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Nov 6, 2018·12 cites·22 claims
- 1295US9234031B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2014·Granted Jan 12, 2016·17 cites·9 claims
- 1395US9217030B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2014·Granted Dec 22, 2015·17 cites·82 claims
- 1494US12195525B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2022·Granted Jan 14, 2025·1 cites·20 claims
- 1594US11028158B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2019·Granted Jun 8, 2021·6 cites·36 claims
- 1694US10906967B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2019·Granted Feb 2, 2021·6 cites·30 claims
- 1794US10414825B2Anti-MCAM antibodies and associated methods of usePROTHENA BIOSCIENCES LTD·Filed 2016·Granted Sep 17, 2019·14 cites·25 claims
- 1894US9879080B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2016·Granted Jan 30, 2018·13 cites·36 claims
- 1993US12479910B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2024·Granted Nov 25, 2025·1 cites·21 claims
- 2093US10906964B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Feb 2, 2021·7 cites·65 claims
- 2193US10875909B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Dec 29, 2020·2 cites·17 claims
- 2293US10723792B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2019·Granted Jul 28, 2020·3 cites·21 claims
- 2393US10407506B2Anti-MCAM antibodies and associated methods of usePROTHENA BIOSCIENCES LTD·Filed 2015·Granted Sep 10, 2019·13 cites·20 claims
- 2493US10081674B2Antibodies recognizing α-synucleinPROTHENA BIOSCIENCES LTD·Filed 2017·Granted Sep 25, 2018·18 cites·26 claims
- 2593US9605056B2Antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2013·Granted Mar 28, 2017·22 cites·22 claims
- 2693US2025268999A1Treatment and Prophylaxis of AmyloidosisPROTHENA BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 2792US11492393B2Tau immunotherapyPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Nov 8, 2022·2 cites·14 claims
- 2892US10494426B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Dec 3, 2019·9 cites·34 claims
- 2992US10301382B2Antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2018·Granted May 28, 2019·10 cites·20 claims
- 3090US10875910B2Antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Dec 29, 2020·2 cites·12 claims
- 3190US10597441B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Mar 24, 2020·4 cites·26 claims
- 3290US10584177B2Anti-MCAM antibodies and associated methods of usePROTHENA BIOSCIENCES LTD·Filed 2017·Granted Mar 10, 2020·6 cites·8 claims
- 3389US10669331B2Antibodies recognizing α-synucleinPROTHENA BIOSCIENCES LTD·Filed 2019·Granted Jun 2, 2020·3 cites·22 claims
- 3489US10407507B2Anti-MCAM antibodies and associated methods of usePROTHENA BIOSCIENCES LTD·Filed 2016·Granted Sep 10, 2019·6 cites·9 claims
- 3589US10059761B2Anti-Laminin4 antibodies specific for LG4-5PROTHENA BIOSCIENCES LTD·Filed 2015·Granted Aug 28, 2018·8 cites·37 claims
- 3688US11926659B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2021·Granted Mar 12, 2024·1 cites·32 claims
- 3786US11584791B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Feb 21, 2023·1 cites·17 claims
- 3885US11692024B2Methods of treating AL amyloidosisPROTHENA BIOSCIENCES LTD·Filed 2020·Granted Jul 4, 2023·2 cites·42 claims
- 3985US10513555B2Antibody formulations and methodsPROTHENA BIOSCIENCES LTD·Filed 2014·Granted Dec 24, 2019·7 cites·23 claims
- 4084US12528858B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2022·Granted Jan 20, 2026·0 cites·7 claims
- 4181US12049498B2Humanized antibodies recognizing sortilinPROTHENA BIOSCIENCES LTD·Filed 2023·Granted Jul 30, 2024·0 cites·10 claims
- 4280US12049497B2Antibodies recognizing sortilinPROTHENA BIOSCIENCES LTD·Filed 2023·Granted Jul 30, 2024·0 cites·9 claims
- 4379US11267877B2Anti-transthyretin antibodiesPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Mar 8, 2022·1 cites·40 claims
- 4479US10654920B2Anti-laminin4 antibodies specific for LG4-5PROTHENA BIOSCIENCES LTD·Filed 2018·Granted May 19, 2020·1 cites·10 claims
- 4579US2024209073A1Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2024·Application pending·0 cites
- 4678US11958896B2Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2018·Granted Apr 16, 2024·1 cites·22 claims
- 4778US2023340094A1Tau ImmunotherapyPROTHENA BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 4876US12240894B2Methods of treating AL amyloidosisPROTHENA BIOSCIENCES LTD·Filed 2023·Granted Mar 4, 2025·0 cites·25 claims
- 4976US2023250161A1Antibodies recognizing tauPROTHENA BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 5075US11345749B2Humanized antibodies that recognize alpha-synucleinPROTHENA BIOSCIENCES LTD·Filed 2020·Granted May 31, 2022·0 cites·5 claims
Showing the top 50 of 108 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when PROTHENA BIOSCIENCES LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →